The COVID-19 pandemic has upended life and has left the world facing an uncertain future. It is thought that a global approach needs to be the focus before life can «return to normal». COVID-19, first identified as a geographically localized viral infection, rapidly spread to become a global pandemic. Eighteen months later, the prediction is that it will recur in waves due to its many mutations. This suggests its recurrence will be similar to the influenza virus. This is of particular concern for the more vulnerable population like pregnant women. In pregnancy the immune response is altered and many pharmaceuticals are contraindicated. Vaccination of pregnant women is still a subject of investigation with trials being carried out in many countries. But in the pregnant population many are vaccine hesitant because of unknown longterm effects for them and for their offspring. Ongoing strategies and alternative methods of preventing the disease need to be investigated. In COVID-19 patients, an alteration of the microbiome composition has been identified, which points towards a related decrease in the integrity of the immune system. Additionally, disease severity has been related to the amount of dysbiosis in the gut flora. Utilizing a therapeutic protocol of prebiotics and probiotics might be a viable alternative in preventing infection or decreasing the risk of severe outcomes when infected with COVID-19.
Author keywords: Pregnancy, Immune System, COVID-19, SarsCoV-2, Microbiome, Gut flora, Pregnancy Immune system, Th1 Immune system, Th2 Immune system
Author affiliation: Chiropractor, Ebikon, Switzerland
Corresponding author: Susanne Williams-Frey—email@example.com
This abstract is reproduced with the permission of the publisher. Click on the above link for free full text. Online access only. PDF